CHEMBIO DIAGNOSTICS, INC.
DelistedCIK 1092662fmd_106B9NSQ6CC3TKVX0ZKC8BWB46Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2022, 51 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 30 | 28 | 24 | 18 | 25 | 35 | 34 | 32 | 48 | 50 |
| Cost of revenue | 17 | 17 | 14 | 9 | 14 | 23 | 22 | 24 | 34 | 39 |
| Gross profit | 12 | 11 | 10 | 8 | 11 | 12 | 12 | 9 | 13 | 11 |
| Research and development | 6 | 5 | 6 | 8 | 9 | 9 | 9 | 10 | 12 | 7 |
| Selling, general and administrative | 5 | 8 | 8 | 8 | 9 | 11 | 16 | 21 | 25 | 24 |
| Total operating expenses | 11 | 12 | 28 | 25 | 30 | 41 | – | – | – | – |
| Operating income | 1 | (2) | (4) | (8) | (6) | (8) | (13) | (23) | (31) | (24) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Other non-operating income (expense) | 0 | 0 | (0) | 0 | 0 | – | – | – | – | – |
| Income before taxes | 1 | (2) | (4) | (8) | (6) | (8) | (14) | (26) | (34) | (23) |
| Income tax expense | 0 | (0) | (1) | 6 | (0) | (0) | (1) | (0) | (0) | 0 |
| Net income from continuing operations | 1 | (1) | (2) | (13) | (6) | (8) | (14) | (26) | (34) | (23) |
| Net income | 1 | (1) | (2) | (13) | (6) | (8) | (14) | (26) | (34) | (23) |